Straumann Holding AG (SAUHF)
USD 115.51
(-0.72%)
USD 115.51
(-0.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 494.17 Million CHF | -21.39% |
| 2022 | 678.32 Million CHF | 5.02% |
| 2021 | 646.96 Million CHF | 154.06% |
| 2020 | 229 Million CHF | -44.86% |
| 2019 | 476.58 Million CHF | 17.86% |
| 2018 | 403.72 Million CHF | 3.38% |
| 2017 | 323.18 Million CHF | 47.2% |
| 2016 | 258.85 Million CHF | 107.31% |
| 2015 | 218.04 Million CHF | -40.66% |
| 2014 | 175.69 Million CHF | 32.94% |
| 2013 | 155.34 Million CHF | 79.18% |
| 2012 | 93.56 Million CHF | -39.86% |
| 2011 | 115.42 Million CHF | -39.12% |
| 2010 | 239.68 Million CHF | -4.61% |
| 2009 | 251.56 Million CHF | 85.82% |
| 2008 | 135.38 Million CHF | -44.21% |
| 2007 | 242.66 Million CHF | 10.15% |
| 2006 | 217.2 Million CHF | 19.75% |
| 2005 | 184.15 Million CHF | 18.54% |
| 2004 | 155.19 Million CHF | 27.47% |
| 2003 | 121.75 Million CHF | 30.41% |
| 2002 | 93.36 Million CHF | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 408.59 Million CHF | 128.93% |
| 2023 Q4 | 178.48 Million CHF | -49.81% |
| 2023 FY | - CHF | -21.39% |
| 2023 Q2 | 355.64 Million CHF | 13.55% |
| 2022 FY | - CHF | 5.02% |
| 2022 Q2 | 379.99 Million CHF | 22.76% |
| 2022 Q4 | 313.2 Million CHF | -17.58% |
| 2021 Q4 | 309.53 Million CHF | -6.25% |
| 2021 Q2 | 330.17 Million CHF | 14.29% |
| 2021 FY | - CHF | 154.06% |
| 2020 FY | - CHF | -44.86% |
| 2020 Q4 | 288.9 Million CHF | 127.75% |
| 2020 Q2 | 126.85 Million CHF | -50.34% |
| 2019 Q4 | 255.44 Million CHF | 20.27% |
| 2019 FY | - CHF | 17.86% |
| 2019 Q2 | 212.38 Million CHF | 5.95% |
| 2018 Q2 | 203.26 Million CHF | 23.11% |
| 2018 FY | - CHF | 3.38% |
| 2018 Q4 | 200.46 Million CHF | -1.38% |
| 2017 FY | - CHF | 47.2% |
| 2017 Q2 | 158.08 Million CHF | 22.3% |
| 2017 Q4 | 165.09 Million CHF | 4.44% |
| 2016 Q2 | 129.6 Million CHF | 21.78% |
| 2016 FY | - CHF | 107.31% |
| 2016 Q4 | 129.25 Million CHF | -0.27% |
| 2015 FY | - CHF | -40.66% |
| 2015 Q4 | 106.42 Million CHF | -4.66% |
| 2015 Q2 | 111.62 Million CHF | 28.41% |
| 2014 Q2 | 88.76 Million CHF | 43.87% |
| 2014 Q4 | 86.92 Million CHF | -2.07% |
| 2014 FY | - CHF | 32.94% |
| 2013 Q4 | 61.69 Million CHF | -21.63% |
| 2013 Q2 | 78.72 Million CHF | 0.0% |
| 2013 FY | - CHF | 79.18% |
| 2012 Q4 | - CHF | 0.0% |
| 2012 FY | - CHF | -39.86% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | - CHF | -39.12% |
| 2010 Q4 | - CHF | 0.0% |
| 2010 FY | - CHF | -4.61% |
| 2009 FY | - CHF | 85.82% |
| 2009 Q4 | - CHF | 0.0% |
| 2008 FY | - CHF | -44.21% |
| 2007 FY | - CHF | 10.15% |
| 2006 FY | - CHF | 19.75% |
| 2005 FY | - CHF | 18.54% |
| 2004 FY | - CHF | 27.47% |
| 2003 FY | - CHF | 30.41% |
| 2002 FY | - CHF | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 51365.102% |
| Ansell Limited | 209.86 Million USD | -135.476% |
| Ansell Limited | 206.3 Million USD | -139.54% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -1053.535% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 30511.502% |
| Psykey, Inc. | -1.29 Million USD | 38251.044% |
| ConvaTec Group Plc | 455.5 Million USD | -8.49% |
| ConvaTec Group Plc | 455.5 Million USD | -8.49% |
| Encision Inc. | -544.19 Thousand USD | 90907.891% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 348574.72% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 449633.339% |
| Innovative MedTech Inc. | -7.67 Million USD | 6539.716% |
| LifePoint, Inc. | -14.2 Million USD | 3579.561% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 8087.264% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 152152.923% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 229697.554% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 121882.032% |
| SmileDirectClub, Inc. | -186.13 Million USD | 365.485% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -10.35% |
| SheerVision, Inc. | -110.53 Thousand USD | 447189.052% |
| United Health Products, Inc. | -2.5 Million USD | 19849.39% |
| Vasamed, Inc. | -4.57 Million USD | 10902.891% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 21958.899% |
| Yubo International Biotech Limited | -1.17 Million USD | 42061.27% |